{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:35:30Z","timestamp":1777394130551,"version":"3.51.4"},"reference-count":39,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2015,7,24]]},"DOI":"10.3233\/jad-143126","type":"journal-article","created":{"date-parts":[[2015,8,4]],"date-time":"2015-08-04T12:22:55Z","timestamp":1438690975000},"page":"373-383","source":"Crossref","is-referenced-by-count":20,"title":["The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"47","author":[{"given":"Luisa S.","family":"Pimentel","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Allard","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Do Carmo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orly","family":"Weinreb","sequence":"additional","affiliation":[{"name":"Abital Pharma Pipeline Ltd., Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Danik","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia E.","family":"Hanzel","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moussa B.","family":"Youdim","sequence":"additional","affiliation":[{"name":"Abital Pharma Pipeline Ltd., Tel Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Claudio","family":"Cuello","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-143126_ref1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1471-4159.2005.03341.x","article-title":"Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases. In vivo selective brain monoamine oxidase inhibition and prevention of MPTP-induced striatal dopamine depletion","volume":"95","author":"Gal","year":"2005","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-143126_ref2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2174\/156720507781788927","article-title":"Neurorescue activity, APP regulation and amyloid-beta peptide reduction by novel multi-functional brain permeable iron- chelating- antioxidants, M-30 and green tea polyphenol, EGCG","volume":"4","author":"Avramovich-Tirosh","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-143126_ref3","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1096\/fj.09-130047","article-title":"Neuroprotective and neuritogenic activities of novel multimodal iron-chelating drugs in motor-neuron-like NSC-34 cells and transgenic mouse model of amyotrophic lateral sclerosis","volume":"23","author":"Kupershmidt","year":"2009","journal-title":"FASEB J"},{"key":"10.3233\/JAD-143126_ref4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1089\/ars.2011.4279","article-title":"The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer\u2019s disease","volume":"17","author":"Kupershmidt","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.3233\/JAD-143126_ref5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1471-4159.2005.03340.x","article-title":"Novel multifunctional neuroprotective ironchelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: In vitro studies on antioxidant activity,prevention of lipid peroxide formation and monoamine oxidaseinhibition","volume":"95","author":"Zheng","year":"2005","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-143126_ref6","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1096\/fj.07-8386com","article-title":"Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators","volume":"21","author":"Zhu","year":"2007","journal-title":"FASEB J"},{"key":"10.3233\/JAD-143126_ref7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3233\/JAD-2010-1349","article-title":"A novel transgenic rat model with a full Alzheimer\u2019s-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment","volume":"20","author":"Leon","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-143126_ref8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bmc.2004.10.037","article-title":"Design, synthesis, and evaluation of novel bifunctional iron-chelators as potential agents for neuroprotection in Alzheimer\u2019s, Parkinson\u2019s, and other neurodegenerative diseases","volume":"13","author":"Zheng","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.3233\/JAD-143126_ref9","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1523\/JNEUROSCI.1144-11.2012","article-title":"Impact of the NGF maturation and degradation pathway on the cortical cholinergic system phenotype","volume":"32","author":"Allard","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-143126_ref10","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.neurobiolaging.2014.03.026","article-title":"Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer\u2019s disease","volume":"35","author":"Hanzel","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-143126_ref11","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.3233\/JAD-143126_ref12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/187152711794488575","article-title":"Microglia phenotype diversity","volume":"10","author":"Olah","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.3233\/JAD-143126_ref13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fncel.2013.00003","article-title":"Quantitating the subtleties of microglial morphology with fractal analysis","volume":"7","author":"Karperien","year":"2013","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-143126_ref14","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","article-title":"Biomarker modeling of Alzheimer\u2019s disease","volume":"80","author":"Jack","year":"2013","journal-title":"Neuron"},{"key":"10.3233\/JAD-143126_ref15","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u2019s disease: Implications for sequence of pathological events in Alzheimer\u2019s disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JAD-143126_ref16","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-143126_ref17","first-page":"171","article-title":"Neurotoxins induceapoptosis in dopamine neurons: Protection byN-propargylamine-1(R)- and (S)-aminoindan, rasagiline and TV1022","author":"Maruyama","year":"2000","journal-title":"J Neural Transm Suppl"},{"key":"10.3233\/JAD-143126_ref18","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1471-4159.2002.01047.x","article-title":"Mitochondrial permeability transition mediates apoptosis induced by N-methyl(R)salsolinol, an endogenous neurotoxin, and is inhibited by Bcl-2 and rasagiline, N-propargyl-1(R)-aminoindan","volume":"82","author":"Akao","year":"2002","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-143126_ref19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1586\/14737175.3.6.737","article-title":"Rasagiline: An anti-Parkinson drug with neuroprotective activity","volume":"3","author":"Youdim","year":"2003","journal-title":"Expert Rev Neurother"},{"key":"10.3233\/JAD-143126_ref20","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1096\/fj.04-1916fje","article-title":"Neuroprotection via pro-survival protein kinase C isoforms associated with Bcl-2 family members","volume":"18","author":"Weinreb","year":"2004","journal-title":"FASEB J"},{"key":"10.3233\/JAD-143126_ref21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12640-009-9070-9","article-title":"Restoration of nigrostriatal dopamine neurons in post-MPTP treatment by the novel multifunctional brain-permeable iron chelator-monoamine oxidase inhibitor drug, M30","volume":"17","author":"Gal","year":"2010","journal-title":"Neurotox Res"},{"key":"10.3233\/JAD-143126_ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2012-120013","article-title":"From anti-Parkinson\u2019s drug rasagiline to novel multitarget iron chelators with acetylcholinesterase and monoamine oxidase inhibitory and neuroprotective properties for Alzheimer\u2019s disease","volume":"30","author":"Zheng","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-143126_ref23","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1007\/s00702-004-0143-x","article-title":"Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson\u2019s disease and other neurodegenerative diseases","volume":"111","author":"Youdim","year":"2004","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-143126_ref24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/156720511794604561","article-title":"Transgenic mice as a model of pre-clinical Alzheimer\u2019s disease","volume":"8","author":"Ferretti","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-143126_ref25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1742-2094-9-62","article-title":"Minocycline corrects early, pre-plaque neuroinflammation and inhibits BACE-1 in a transgenic model of Alzheimer\u2019s disease-like amyloid pathology","volume":"9","author":"Ferretti","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-143126_ref26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.neuroscience.2003.11.040","article-title":"Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP","volume":"124","author":"Butler","year":"2004","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-143126_ref27","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.cmet.2013.11.002","article-title":"TNF-\u03b1 mediates PKR-dependent memory impairment and brainIRS-1 inhibition induced by Alzheimer\u2019s \u03b2-amyloidoligomers in mice and monkeys","volume":"18","author":"Lourenco","year":"2013","journal-title":"Cell Metab"},{"key":"10.3233\/JAD-143126_ref28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0361-9230(03)00088-1","article-title":"Cerebral pattern of pro- and anti-inflammatory cytokines in dementias","volume":"61","author":"Tarkowski","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.3233\/JAD-143126_ref29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/11310810-000000000-00000","article-title":"Tumour necrosis factor modulation for treatment of Alzheimer\u2019s disease: Rationale and current evidence","volume":"23","author":"Tobinick","year":"2009","journal-title":"CNS Drugs"},{"key":"10.3233\/JAD-143126_ref30","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/S0021-9258(18)53813-8","article-title":"Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells","volume":"268","author":"Hattori","year":"1993","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-143126_ref31","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.ajpath.2011.07.001","article-title":"Ablation of TNF-RI\/RII expression in Alzheimer\u2019s disease mice leads to an unexpected enhancement of pathology: Implications for chronic pan-TNF-\u03b1 suppressive therapeutic strategies in the brain","volume":"179","author":"Montgomery","year":"2011","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-143126_ref32","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/jnc.12633","article-title":"DJ-1 deficiency triggers microglia sensitivity to dopamine toward a pro-inflammatory phenotype that is attenuated by rasagiline","volume":"129","author":"Trudler","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-143126_ref33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.mad.2012.03.001","article-title":"Neuroprotection by the multitarget iron chelator M30 on age-related alterations in mice","volume":"133","author":"Kupershmidt","year":"2012","journal-title":"Mech Ageing Dev"},{"key":"10.3233\/JAD-143126_ref34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/glia.20338","article-title":"Minocycline affects microglia activation, Abeta deposition, and behavior in APP-tg mice","volume":"53","author":"Seabrook","year":"2006","journal-title":"Glia"},{"key":"10.3233\/JAD-143126_ref35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer\u2019s amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.3233\/JAD-143126_ref36","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.3233\/JAD-143126_ref37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"},{"key":"10.3233\/JAD-143126_ref38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","article-title":"Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake","volume":"62","author":"Li","year":"2009","journal-title":"Neuron"},{"key":"10.3233\/JAD-143126_ref39","doi-asserted-by":"crossref","first-page":"e27291","DOI":"10.1371\/journal.pone.0027291","article-title":"Alzheimer\u2019s disease and non-demented high pathology control nonagenarians: Comparing and contrasting the biochemistry of cognitively successful aging","volume":"6","author":"Maarouf","year":"2011","journal-title":"PLoS One"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-143126","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:30Z","timestamp":1777370550000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-143126"}},"subtitle":[],"editor":[{"given":"Domenico","family":"Pratico","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,7,24]]},"references-count":39,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-143126","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,24]]}}}